Related Experiment Videos
A new human prostate carcinoma cell line, 22Rv1
R M Sramkoski1, T G Pretlow, J M Giaconia
1Cancer Research Center, Case Western Reserve University, Cleveland, Ohio 44106, USA.
In Vitro Cellular & Developmental Biology. Animal
|August 26, 1999
Summary
A new human prostate cancer cell line, CWR22R, was developed from a xenograft model. This cell line retains key characteristics of prostate cancer, offering a valuable research tool for studying the disease.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Prostate cancer is a significant health concern with limited available cell line models.
- The CWR22R cell line was derived from a human prostatic carcinoma xenograft (CWR22R) that underwent serial propagation.
- This xenograft was passaged in mice following castration-induced regression and relapse of the parental CWR22 xenograft.
Purpose of the Study:
- To establish and characterize a novel cell line representative of human prostatic carcinoma.
- To evaluate the biological and genetic properties of the derived cell line for its utility in cancer research.
Main Methods:
- Cell line derivation from a human prostatic carcinoma xenograft (CWR22R).
- Flow cytometry and cytogenetic analysis to determine DNA content and karyotype.
- Tumorigenicity assessment in nude mice and characterization of tumor morphology.
- Analysis of prostate specific antigen (PSA) expression, androgen receptor (AR) status, and response to growth factors (dihydrotestosterone, epidermal growth factor, transforming growth factor-beta1).
Main Results:
- The CWR22R cell line exhibits a hyper DNA-diploid stem line with two distinct cytogenetic sublines.
- The karyotype is similar to the parent xenograft with approximately 50 chromosomes.
- Tumors formed in nude mice display morphology consistent with the original xenografts.
- The cell line expresses prostate specific antigen and shows weak androgen stimulation, with confirmed androgen receptor presence.
- Growth is stimulated by epidermal growth factor but not inhibited by transforming growth factor-beta1.
Conclusions:
- The CWR22R cell line is a valuable new model for human prostate cancer research.
- It retains key characteristics of the original tumor, including PSA expression and androgen receptor signaling.
- This cell line provides a platform for investigating prostate cancer biology and therapeutic strategies.